Mature Versus Registration Studies of Immuno-Oncology Agents: Does Value Improve With Time?

PURPOSE:A unique feature of immuno-oncology agents is the potential for durable survival for a subset of patients; however, this benefit usually cannot not be seen in the early published data used ...